SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 58.70 |
| Enterprise Value ($M) | 56.30 |
| Book Value ($M) | -9.86 |
| Book Value / Share | -0.11 |
| Price / Book | -5.95 |
| NCAV ($M) | -12.81 |
| NCAV / Share | -0.14 |
| Price / NCAV | -4.58 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -2.12 |
| Return on Assets (ROA) | -0.94 |
| Return on Equity (ROE) | -3.87 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.68 |
| Current Ratio | 1.76 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 51.18 |
| Assets | 54.13 |
| Liabilities | 63.99 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 7.57 |
| Operating Income | -65.04 |
| Net Income | -76.58 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -60.93 |
| Cash from Investing | -0.02 |
| Cash from Financing | 37.73 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Armistice Capital, Llc | 9.99 | ||
| 13G/A | Perceptive Advisors Llc | 5.10 | -40.58 | |
| 13G | Caligan Partners LP | 9.99 | ||
| 13D/A | Manning Paul B | 49.90 | 241.17 | |
| 13G/A | Avoro Capital Advisors LLC | 0.00 | -100.00 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 229,515 | 758,380 | 30.26 | |
| 82,727 | 363,377 | 22.77 | |
| 104,806 | 430,721 | 24.33 | |
| 72,211 | 199,822 | 36.14 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| VCEL – Vericel Corporation | VERA – Vera Therapeutics, Inc. |
| VNDA – Vanda Pharmaceuticals Inc. | WVE – Wave Life Sciences Ltd. |
| XENE – Xenon Pharmaceuticals Inc. |
Financial data and stock pages provided by
Fintel.io